The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
November 23rd 2024
With approval, acoramaidis becomes the first agent with a label specifying near-complete stabilization of TTR.
November 18th 2024
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Internet-based Interventions Help Reduce Coronary Heart Disease Risk
June 30th 2009According to a recent study, the communication via phone and Internet between patients and healthcare providers is “an effective way to reduce risk factors for coronary heart disease and the risk of further events after a heart attack.”
Will Your EMR Installation End Up a Sweet Success, or Will Your Plans Go Sour?
June 9th 2009Installing an EMR in your practice is a long, difficult, painstaking process that requires extensive research and due diligence, total commitment from staff, intensive training, and full support from a dedicated vendor.
Which Is a Better Treatment Option for Type 2 Diabetes: Heart Surgery or Medication?
June 9th 2009At the American Diabetes Association 69th Scientific Sessions, researchers presented their results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes study, which evaluated patients diagnosed with type 2 diabetes and stable heart disease.
Statins After a Stroke Significantly Reduce Recurrence Risk
June 8th 2009For the last several years, a statin agent has been the "top" prescribed drug in the US, as well as the rest of the world (based on cost), and statins were the largest selling US drug class (also by cost) for a number of years, falling to second in 2008 only because of generic availability.
The Latest News on the Obama Administration's Plans for Healthcare Reform
May 15th 2009Pundits, analysts, and other industry observers have been weighing in with their thoughts on what the President's proposals will call for, what effect they may have on the nation's healthcare system, their chances of being enacted, and how we're going to pay for it all.
Chemical in Plastic Medical Devices May Be Responsible for Decreased Heart Function
May 12th 2009A chemical often used to create plastic medical devices has been shown to impair heart function in rats, and may be why side affects like loss of taste and short-term memory problems occur after medical procedures that require blood to be circulated outside of the body in plastic tubing.